← All institutions

Morgan Stanley

275 reports

Reports from this institution

Morgan Stanley

Morgan Stanley: Indian IT services: AI revenue remains too small to offset pressure on legacy businesses; growth may reach an inflection point at the end of 2028

Morgan Stanley believes India’s IT services industry is in a transition phase of AI deployment: competition and technological change are weighing on existing businesses, while new businesses still account for a small share. The bank expects a valuation rerating may precede an inflection point in revenue growth, but share-price performance will remain divergent.

Morgan Stanley

Morgan Stanley: Lineage third-quarter preview: Cold-storage demand stabilizes, but freight and interest weigh on per-share earnings

Morgan Stanley expects Lineage’s third-quarter results to be broadly in line with consensus, but higher oil prices and interest costs may prompt the company to lower its full-year AFFO per share guidance. Rising cold-storage inventories and slowing new supply show signs of improvement, while excess capacity, pricing and logistics costs continue to constrain profit recovery.

Morgan Stanley

Morgan Stanley: Kelun Pharmaceutical’s first-line lung cancer trial exceeds expectations: progression-free survival extended, but overall survival data remain early

Morgan Stanley believes sac-TMT plus pembrolizumab delivered a progression-free survival benefit beyond recent market expectations in a Chinese phase III lung cancer trial. Its safety profile also supports its potential to replace chemotherapy; efficacy in patients with brain metastases and results in certain subgroups remain important questions.